Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 937–960 of 1,285 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Model 2 Clear all

Conditions: Acne Vulgaris
Interventions: FMX101 vehicle, Hydro-alcohol solution; Drug · Other
Lead sponsor: Vyne Therapeutics Inc.; Industry
Eligibility: 12 Years to 40 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Diego, California

Conditions: Type 2 Diabetes
Interventions: eButton, Continuous Glucose Monitoring (CGM); Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 99 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Autism
Interventions: Discrete Trial Training, Interpersonal Developmental Approach; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 33 Months to 54 Months
Enrollment: 192 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 3
States / cities: Los Angeles, California • Baltimore, Maryland • Rochester, New York

Conditions: Breast Cancer
Interventions: Verbal and Written Instruction, Verbal and Written Plus Simulation; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 19 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Dehydrated Hereditary Stomatocytosis
Interventions: Senicapoc (synonyms: ICA-17043; 2,2-bis-(4-fluorophenyl)-2-phenylacetamide); Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Jansen's Metaphyseal Chondrodysplasia
Interventions: PTH-IA; Drug
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 3 Years to 100 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetes
Interventions: Proactive population care (active application of HOAP principles in patients flagged as high risk for hypoglycemia), Usual care, after system-side dissemination of HOAP; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Pleasanton, California

Conditions: Meniscus Tear, Meniscus; Derangement, Meniscus Lesion, Meniscus Disorder
Interventions: Fisetin, Placebo oral capsule; Drug
Lead sponsor: Austin V Stone; Other
Eligibility: 18 Years to 45 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Massage
Interventions: Quantifiable Soft Tissue Manipulation (QSTM); Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 106 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pulmonary Disease
Interventions: Biosamples from airway and blood; Other
Lead sponsor: Boston University; Other
Eligibility: 50 Years to 79 Years
Enrollment: 665 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2027
U.S. locations: 15
States / cities: Los Angeles, California • San Diego, California • Denver, Colorado + 9 more

Conditions: Dental Caries
Interventions: 0.425 % w/w phytate,1150ppm F, 0.85 % w/w phytate,1150ppm F, 0.85 % w/w phytate,0.3%ZnCl2 0.5% sodium citrate, 1150ppm F, 0 ppm F, 1150ppm F, 0.3%ZnCl2, 0.5% sodium citrate, 1150ppm F; Drug · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Healthy Volunteers
Interventions: Phlebotomy - Blood sampling for GP88 at MM, SOC Tissue biopsy; Other · Procedure
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 40 Years to 64 Years · Female only
Enrollment: 417 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Baltimore, Maryland • Glen Burnie, Maryland

Conditions: Nicotine Dependence
Interventions: Motivational Interviewing, Psychoeducation; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Spinal Cord Injury
Interventions: Multi-Family Group Treatment, SCI Education Control Group; Behavioral
Lead sponsor: St. Luke's Rehabilitation Institute; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Degenerative Disc Disease
Interventions: Intradiscal rhGDF-5, Water for injection; Drug · Other
Lead sponsor: DePuy Spine; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 10
States / cities: Phoenix, Arizona • Santa Monica, California • Durango, Colorado + 7 more

Conditions: Suicide Prevention
Interventions: HAVEN-Connect, HAVEN Suicide Prevention; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 13 Years to 19 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: New York, New York • Rochester, New York

Conditions: Clinical Deterioration
Interventions: PICTURE-Pediatric scores and alerts, Control Arm - Scores and alerts hidden; Device · Other
Lead sponsor: University of Michigan; Other
Eligibility: 30 Days to 25 Years
Enrollment: 375 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: H1N1 Influenza Healthy Volunteers
Interventions: CR6261, Placebo; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Age-related Macular Degeneration
Interventions: CNTO 2476, iTrack Model 275 micro catheter; Biological · Procedure
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 50 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 2
States / cities: Arcadia, California • Philadelphia, Pennsylvania

Conditions: Sleep Disturbance, Stress, Psychological, REM Sleep Measurement
Interventions: NEUSleeP system (FUS-EEG wearable device), BrainSonix Pulsar 1002; Device
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 50 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Dental Caries
Interventions: Test Dentifrice, Reference Dentifrice, Negative Control Dentifrice; Drug
Lead sponsor: HALEON; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Behavior, Consumer, Health Knowledge, Attitudes, Practice, Health Attitude
Interventions: RANAS Behavior Change Intervention, Infrastructural Intervention - Direct Delivery; Behavioral · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 781 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Malaria
Interventions: Ad35.CS.01/Ad26.CS.01 low dose (1 x 10^10 vp), Ad 35.CS.01/Ad 26.CS.01 high dose (5 x 10^10 vp), Placebo; Biological
Lead sponsor: Crucell Holland BV; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Herpes Zoster, Pneumococcal Infections
Interventions: Enhanced immunization delivery model, Immunization update; Behavioral · Other
Lead sponsor: Auburn University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Auburn, Alabama • Claremont, California

Search by objective public record fields.

A Study Comparing Two Topicals in the Treatment of Acne Vulgaris

Wearable Sensors and Artificial Intelligence for Carbohydrate Counting

Interventions for Communication in Autism Network

Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers

Senicapoc and Dehydrated Stomatocytosis

Safety and Efficacy of PTH-IA

Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients

Enhancing Recovery Through a Combined Mechanobiologic Intervention Following Meniscus Repair

The Reproducibility and Consistency of Instrument-assisted Soft Tissue Manipulation

DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer

Efficacy of Three Toothpastes Using an in Situ Caries Model

1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer

Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMI

Comparison of Two Psycho-educational Family Group Interventions for Persons With SCI and Their Caregivers

A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Degeneration

HAVEN-Connect Youth Suicide Prevention

Predicting ICU Transfers and Other Unforeseen Events (PICTURE)-Pediatric

Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Volunteer Human Challenge Model

A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration

Wearable Neural Interfacing System for REM Sleep Restoration and Enhancement

A Clinical Study to Assess an Experimental Dentifrice in an Experimental Model of Early Stage Caries

Encouraging LPG Adoption in Ghana: A Factorial Randomized Clinical Trial to Enhance LPG Adoption & Sustained Use

A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model

Enhancing a Sustainable Pharmacy-based Immunization Program in Two States